Entecavir maleate versus Entecavir in Chinese patients with HBeAg-Positive Chronic Hepatitis B: Results at 48 and 96 weeks of a Randomized Double-blind Multicenter Clinical Trial

被引：0
|
作者：
Yu, Yanyan [1 ]
Xu, Jinghang [1 ]
Tang, Hong [2 ]
Zhang, Dazhi [3 ]
Mao, Qing [4 ]
Li, Jun [5 ]
Xu, Zhongnan [6 ]
Zhang, Xiquan [6 ]
Dai, Jun [6 ]
Si, Chongwen [1 ]
机构：
[1] Peking Univ, Dept Infect Dis, Hosp 1, Beijing 100871, Peoples R China
[2] Sichuan Univ, Dept Infect Dis, W China Hosp, Chengdu 610064, Peoples R China
[3] Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 2, Chongqing, Peoples R China
[4] Third Mililary Med Univ, Dept Infect Dis, Affiliated Hosp 1, Chongqing, Peoples R China
[5] Nanjing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[6] Jiangsu Chia Tai Tianqing Pharmaceut Co Ltd, Nanjing, Jiangsu, Peoples R China
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
417
引用
收藏
页码：397A / 398A
页数：2
相关论文
共 50 条
  • [1] Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B
    Gish, Robert G.
    Lok, Anna S.
    Chang, Ting-Tsung
    De Man, Robert A.
    Gadano, Adrian
    Sollano, Jose
    Han, Kwang-Hyub
    Chao, You-Chen
    Lee, Shou-Dong
    Harris, Melissa
    Yang, Joanna
    Colonno, Richard
    Brett-Smith, Helena
    GASTROENTEROLOGY, 2007, 133 (05) : 1437 - 1444
  • [2] EVALUATION OF THE EFFICACY OF ENTECAVIR VERSUS ADEFOVIR IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS THERAPY AT 96 WEEKS
    Sun, Aimin
    Cheng, Haowei
    Zhao, Liqun
    Yang, Huiyu
    Yang, Guojie
    HEPATOLOGY, 2010, 52 (04) : 550A - 550A
  • [3] Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial
    Li, Xiaoke
    Zhou, Daqiao
    Chi, Xiaoling
    Li, Qin
    Wang, Li
    Lu, Bingjiu
    Mao, Dewen
    Wu, Qikai
    Wang, Xianbo
    Zhang, Mingxiang
    Xue, Jingdong
    Li, Yong
    Lu, Wei
    Guo, Jianchun
    Jiang, Feng
    Zhang, Xinwei
    Li, Zhiguo
    Yang, Xianzhao
    Guo, Hui
    Gan, Danan
    He, Liyun
    Luo, Lin
    Zhang, Ludan
    Du, Hongbo
    Ye, Yong'an
    HEPATOLOGY INTERNATIONAL, 2020, 14 (06) : 985 - 996
  • [4] Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial
    Xiaoke Li
    Daqiao Zhou
    Xiaoling Chi
    Qin Li
    Li Wang
    Bingjiu Lu
    Dewen Mao
    Qikai Wu
    Xianbo Wang
    Mingxiang Zhang
    Jingdong Xue
    Yong Li
    Wei Lu
    Jianchun Guo
    Feng Jiang
    Xinwei Zhang
    Zhiguo Li
    Xianzhao Yang
    Hui Guo
    Danan Gan
    Liyun He
    Lin Luo
    Ludan Zhang
    Hongbo Du
    Yong’an Ye
    Hepatology International, 2020, 14 : 985 - 996
  • [5] A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of Chinese chronic hepatitis B predominantly genotype B or C: results at week 240
    Xu, J. -H.
    Jing, C. -D.
    Chen, X. -F.
    Wang, S.
    Zeng, Z.
    Si, C. -W.
    Li, J.
    Mao, Q.
    Zhang, D. -Z.
    Tang, H.
    Sheng, J. -F.
    Chen, X. -Y.
    Ning, Q.
    Shi, G. -F.
    Xie, Q.
    Dai, J.
    Zhang, X. -Q.
    Xu, Z. -N.
    Yu, Y. -Y.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S517 - S518
  • [6] A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of Chinese chronic hepatitis B predominantly genotype B or C: results at week 144
    Xu, Jinghang
    Yu, Yanyan
    Si, Chongwen
    Zeng, Zheng
    Li, Jun
    Mao, Qing
    Zhang, Dazhi
    Tang, Hong
    Sheng, Ji-Fang
    Chen, Xinyue
    Ning, Qin
    Shi, Guangfeng
    Xie, Qing
    Zhang, Xiquan
    Dai, Jun
    Xu, Zhongnan
    HEPATOLOGY, 2016, 64 : 925A - 925A
  • [7] Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Zhu, Xiao-Jun
    Sun, Xue-Hua
    Zhou, Zheng-Hua
    Liu, Shun-Qing
    Lv, Hua
    Li, Man
    Li, Lu
    Gao, Yue-Qiu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [8] A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B
    Zeng, MinDe
    Mao, YiMin
    Yao, GuangBi
    Wang, Hao
    Hou, JinLin
    Wang, YaoZong
    Ji, Beulah N.
    Chang, Chai-Ni P.
    Barker, Keith F.
    HEPATOLOGY, 2006, 44 (01) : 108 - 116
  • [9] A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B
    Fen-Yu Ren
    World Journal of Gastroenterology, 2007, (31) : 4264 - 4267
  • [10] A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B
    Ren, Fen-Yu
    Piao, Dong-Ming
    Piao, Xi-Xu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (31) : 4264 - 4267
12345